NCT04648280: Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Sponsor: PENTA Foundation. Phase: PHASE1. Conditions: HIV Infections With Multi Drug Resistant Virus